Clinical Radiology
Volume 65, Issue 5 , Pages 408-420 , May 2010

Follicular non-Hodgkin's lymphoma

  • D. Hayashi

      Affiliations

    • Department of Radiology, Boston University School of Medicine, 820 Harrison Avenue, FGH Building, 3rd Floor, Boston, MA 02118, USA
    • Corresponding Author InformationGuarantor and correspondent: D. Hayashi, Department of Radiology, Boston University School of Medicine, 820 Harrison Avenue, FGH Building, 3rd Floor, Boston, MA 02118, USA. Tel.: +1 617 414 4957; fax: +1 617 638 6616.
    • ,
  • J.C. Lee

      Affiliations

    • Department of Pathology, Boston University School of Medicine, Boston, MA 02118, USA
    • ,
  • B. Devenney-Cakir

      Affiliations

    • Department of Radiology, Boston University School of Medicine, 820 Harrison Avenue, FGH Building, 3rd Floor, Boston, MA 02118, USA
    • ,
  • S. Zaim

      Affiliations

    • Department of Radiology Services, Synarc Inc., San Francisco, CA, USA
    • ,
  • S. Ounadjela

      Affiliations

    • Department of Radiology Services, Synarc Inc., San Francisco, CA, USA
    • ,
  • P. Solal-Céligny

      Affiliations

    • Department of Hematology, Centre Jean Bernard, Le Mans, France
    • ,
  • M. Juweid

      Affiliations

    • Department of Radiology, University of Iowa, Iowa City, IA, USA
    • ,
  • A. Guermazi

      Affiliations

    • Department of Radiology, Boston University School of Medicine, 820 Harrison Avenue, FGH Building, 3rd Floor, Boston, MA 02118, USA

Received 24 November 2009 ,Revised 6 January 2010 ,Accepted 8 January 2010.

References 

  1. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood. 1997;89:3909–3918
  2. Friedberg JW. Treatment of follicular non-Hodgkin's lymphoma: the old and the new. Semin Hematol. 2008;45(Suppl. 2):S2–S6
  3. Maloney DG. Follicular NHL: from antibodies and vaccines to graft-versus-lymphoma effects. Hematology Am Soc Hematol Educ Program. 2007;226–232
  4. Vitolo U, Ferreri AJM, Montoto S. Follicular lymphomas. Crit Rev Oncol Hematol. 2008;66:248–261
  5. Rosenberg SA. Follicular lymphoma revisited. J Clin Oncol. 2008;28:515–516
  6. Rohatiner AZS, Lister TA. The clinical course of follicular lymphoma. Best Pract Res Clin Haematol. 2005;18:1–10
  7. Anis M, Irshad A. Imaging of abdominal lymphoma. Radiol Clin North Am. 2008;46:265–285
  8. Matasar MJ, Zelenetz AD. Overview of lymphoma diagnosis and management. Radiol Clin North Am. 2008;46:175–198
  9. Allen-Auerbach M, de Vos S, Czernin J. The impact of fluorodeoxyglucose-positron emission tomography in primary staging and patient management in lymphoma patients. Radiol Clin North Am. 2008;46:199–211
  10. Cheson BD. New staging and response criteria for non-Hodgkin lymphoma and Hodgkin lymphoma. Radiol Clin North Am. 2008;46:213–223
  11. Aiken AH, Glastonbury C. Imaging Hodgkin and non-Hodgkin lymphoma in the head and neck. Radiol Clin North Am. 2008;46:363–378
  12. Haque S, Law M, Abrey LE, et al. Imaging of lymphoma of the central nervous system, spine and orbit. Radiol Clin North Am. 2008;46:339–361
  13. Hwang S. Imaging of lymphoma of the musculoskeletal system. Radiol Clin North Am. 2008;46:379–396
  14. Gollub MJ. Imaging of gastrointestinal lymphoma. Radiol Clin North Am. 2008;46:287–312
  15. Schoder H, Moskowitz C. PET imaging for response assessment in lymphoma: potential and limitations. Radiol Clin North Am. 2008;46:225–241
  16. Groves FD, Linet MS, Travis LB, et al. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst. 2000;92:1240–1251
  17. Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25:579–586
  18. Carbone PP, Kaplan HS, Musshoff K, et al. Report of the committee on Hodgkin's disease staging classification. Cancer Res. 1971;31:1860–1861
  19. Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol. 1989;7:1630–1636
  20. Solal-Celigny P, Roy P, Colombat P, et al. Follicular lymphoma international prognostic index. Blood. 2004;104:1258–1265
  21. Federico M, Bellei M, Marcheselli L, et al. Follicular Lymphoma International Prognostic Index 2: a new progostic index for follicular lymphoma developed by the International Follicular Lymphoma Prognostic Factor Project. J Clin Oncol. 2009;27:
  22. Rambaldi A, Lazzari M, Manzoni C, et al. Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma. Blood. 2002;99:856–862
  23. Juweid ME, Stroobant S, Hoekstra OS, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol. 2007;25:571–578
  24. Sacchi S, Marcheselli L, Bari A, et al. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study. Haematologica. 2008;93:398–404

PII: S0009-9260(10)00060-7

doi: 10.1016/j.crad.2010.01.010

Clinical Radiology
Volume 65, Issue 5 , Pages 408-420 , May 2010

Article Tools

* Image Usage & Resolution